Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Shapiro

Showing results (41-50 of 413) with videos related to

Pageof 42
Sort By:
European Journal of Preventive Cardiology|September 19, 2025
Aspirin and Lipoprotein(a): Lessons from Replication at ScaleMichael D Shapiro, Massimiliano Ruscica
Journal of Clinical Medicine|August 12, 2022
Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual RiskRishi Rikhi, Michael D Shapiro
JACC. Asia|November 7, 2022
The PCSK9 Problem: Is it Predictive, Punitive, or Puzzling?Nathalie Pamir, Michael D Shapiro
International Journal of Cardiology|September 3, 2005
Carcinoid heart disease arising from an ovarian teratomaMichael D Shapiro, Sam Hanon
JACC. Cardiovascular Imaging|November 19, 2018
Reclassifying Risk in Familial Hypercholesterolemia: The Power of a Coronary Artery Calcium Score of ZeroMichael D Shapiro, Ron Blankstein
Journal of Clinical Lipidology|October 16, 2018
"Taking a look under the hood"-imaging the phenotypic heterogeneity of familial hypercholesterolemiaMichael D Shapiro, Sergio Fazio
American Journal of Preventive Cardiology|August 25, 2020
Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) futureMichael D Shapiro, Sergio Fazio
Journal of Clinical Lipidology|June 25, 2018
Withdrawn: "Taking a look under the hood"-Imaging the phenotypic heterogeneity of familial hypercholesterolemiaMichael D Shapiro, Sergio Fazio
Journal of the American College of Cardiology|July 30, 2021
Closing the Glycemic Divide: The Time for Preventive Cardiology Is NowMichael D Shapiro, Borja Ibanez
Progress in Cardiovascular Diseases|September 15, 2025
APOC3 inhibition: The strongest case yet for triglyceride targetingMichael D Shapiro, Leandro Slipczuk
Pageof 42

Showing results (41-50 of 413) with videos related to

Sort By:
Pageof 42
European Journal of Preventive Cardiology|September 19, 2025
Aspirin and Lipoprotein(a): Lessons from Replication at ScaleMichael D Shapiro, Massimiliano Ruscica
Journal of Clinical Medicine|August 12, 2022
Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual RiskRishi Rikhi, Michael D Shapiro
JACC. Asia|November 7, 2022
The PCSK9 Problem: Is it Predictive, Punitive, or Puzzling?Nathalie Pamir, Michael D Shapiro
International Journal of Cardiology|September 3, 2005
Carcinoid heart disease arising from an ovarian teratomaMichael D Shapiro, Sam Hanon
JACC. Cardiovascular Imaging|November 19, 2018
Reclassifying Risk in Familial Hypercholesterolemia: The Power of a Coronary Artery Calcium Score of ZeroMichael D Shapiro, Ron Blankstein
Journal of Clinical Lipidology|October 16, 2018
"Taking a look under the hood"-imaging the phenotypic heterogeneity of familial hypercholesterolemiaMichael D Shapiro, Sergio Fazio
American Journal of Preventive Cardiology|August 25, 2020
Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) futureMichael D Shapiro, Sergio Fazio
Journal of Clinical Lipidology|June 25, 2018
Withdrawn: "Taking a look under the hood"-Imaging the phenotypic heterogeneity of familial hypercholesterolemiaMichael D Shapiro, Sergio Fazio
Journal of the American College of Cardiology|July 30, 2021
Closing the Glycemic Divide: The Time for Preventive Cardiology Is NowMichael D Shapiro, Borja Ibanez
Progress in Cardiovascular Diseases|September 15, 2025
APOC3 inhibition: The strongest case yet for triglyceride targetingMichael D Shapiro, Leandro Slipczuk
Pageof 42